Insider Transactions Reported by 21 Insiders of Ventyx Biosciences, Inc.

Symbol
VTYX on Nasdaq
Location
San Diego, CA

Insiders trading volume in the past year

Ventyx Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
NSV Partners III LP 10%+ Owner $38,381,603 24 Jun 2024
NSV Investments I, L.P. 10%+ Owner $35,776,685 25 Oct 2021
Raju Mohan CEO AND PRESIDENT, Director $18,372,270 -$365,461 -2% 17 Dec 2025
Somu Subramaniam Director $9,516,023 05 Jun 2025
John Nuss Chief Scientific Officer $3,799,741 -$99,859 -2.6% 17 Dec 2025
Cormorant Asset Management, LP Former 10% Owner $2,986,881 25 Oct 2021
Christopher Krueger Chief Business Officer $1,613,478 02 Apr 2024
Sheila Gujrathi Director $300,573 05 Jun 2025
Martin Auster Chief Financial Officer $204,778 02 Apr 2024
William J. Sandborn President and Chief Medical Officer $153,723 31 Aug 2023
Mark S. Forman Chief Medical Officer $6,180 17 Nov 2025
Roy Gonzales Senior VP, Finance $5,472 17 Nov 2025
ALLISON HULME Director 05 Jun 2025
Matthew Richard Moore Chief Operating Officer 02 Jan 2025
venBio Global Strategic Fund III, L.P. Other*, 10%+ Owner 09 Jun 2022
Jorn Drappa Chief Medical Officer 04 Feb 2022
Aaron Royston Director 09 Jun 2022
Richard Gaster Director 09 Jun 2022
William Richard White Director 05 Jun 2025
Onaiza Cadoret-Manier Director 05 Jun 2025
Jigar Choksey Director 09 Jun 2022

Recent Insider Transactions by Companies or Individuals for Ventyx Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.